欢迎您!
东篱公司
退出
申报数据库
申报指南
立项数据库
成果数据库
期刊论文
会议论文
著 作
专 利
项目获奖数据库
位置:
成果数据库
>
期刊
> 期刊详情页
Efficacy and Immune Mechanisms of Cetuximab for Treatment of Metastatic Colorectal Cancer.
期刊名称:Clinical Oncology and Cancer Research
时间:2011.11.11
页码:207-214
相关项目:脂联素对TH17细胞及非可控性炎症恶性转化的调节机制
作者:
Hao Zhuang|Zhenyi Xue|Lu Wang|Xiao-yan Li|Ning Zhang|Rongxin Zhang|
同期刊论文项目
脂联素对TH17细胞及非可控性炎症恶性转化的调节机制
期刊论文 11
同项目期刊论文
Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity.
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates expe
Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarco
Embelin suppresses dendritic cell functions and limits autoimmune encephalomyelitis through the TGF-
miRNA与糖尿病肾病关系的研究进展
Epigenetics: The language of the cell.
Regulatory non-coding RNAs: revolutionizing the RNA world.
Thermo-sensitive injectable hydrogel enhances the anti-tumor effect of embelin in mouse hepatocellul
微小核糖核酸与糖尿病肾病关系的研究进展
Efficacy and Immune Mechanisms of Cetuximab for the Treatment of Metastatic Colorectal Cancer